Skip to main content

CORRECTION article

Front. Med., 04 May 2022
Sec. Rheumatology
Volume 9 - 2022 | https://doi.org/10.3389/fmed.2022.923790

Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study

This article is a correction to:

  1. The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study

    1. Read original article
\nEnnio Giulio Favalli,*&#x;Ennio Giulio Favalli1,2*†Andrea Gobbini&#x;Andrea Gobbini3†Mauro Bombaci&#x;Mauro Bombaci3†Gabriella Maioli,Gabriella Maioli1,2Martina BiggioggeroMartina Biggioggero1Elisa PesceElisa Pesce3Andrea FavalliAndrea Favalli3Martina MartinovicMartina Martinovic3Tanya FabbrisTanya Fabbris3Edoardo MarchisioEdoardo Marchisio4Alessandra Bandera,,Alessandra Bandera5,6,7Andrea Gori,,Andrea Gori5,6,7Sergio Abrignani&#x;Sergio Abrignani3†Renata Grifantini&#x;Renata Grifantini3†Roberto Caporali,&#x;Roberto Caporali1,2†
  • 1Division of Clinical Rheumatology, ASST Gaetano Pini-CTO Institute, Milan, Italy
  • 2Department of Clinical Sciences and Community Health, Research Center for Adult and Pediatric Rheumatic Diseases, Università degli Studi di Milano, Milan, Italy
  • 3Istituto Nazionale Genetica Molecolare, Padiglione Romeo ed Enrica Invernizzi, Milan, Italy
  • 4Dia.Pro, Diagnostic Bioprobes Srl, Milan, Italy
  • 5Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
  • 6Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
  • 7Centre for Multidisciplinary Research in Health Science (MACH), Università degli Studi di Milano, Milan, Italy

A Corrigendum on
The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study

by Favalli, E. G., Gobbini, A., Bombaci, M., Maioli, G., Biggioggero, M., Pesce, E., Favalli, A., Martinovic, M., Fabbris, T., Marchisio, E., Bandiera, A., Gori, A., Abrignani, S., Grifantini, R., and Caporali, R. (2022). Front. Med. 9:850858. doi: 10.3389/fmed.2022.850858

In the original article, an author name was incorrectly spelled as “Alessandra Bandiera.” The correct spelling is “Alessandra Bandera.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: seroprevalence, SARS-CoV-2, humoral response, rheumatic musculoskeletal diseases, disease-modifying anti-rheumatic drugs, risk of infection, COVID-19

Citation: Favalli EG, Gobbini A, Bombaci M, Maioli G, Biggioggero M, Pesce E, Favalli A, Martinovic M, Fabbris T, Marchisio E, Bandera A, Gori A, Abrignani S, Grifantini R and Caporali R (2022) Corrigendum: The Impact of Anti-rheumatic Drugs on the Seroprevalence of Anti-SARS-CoV-2 Antibodies in a Cohort of Patients With Inflammatory Arthritis: The MAINSTREAM Study. Front. Med. 9:923790. doi: 10.3389/fmed.2022.923790

Received: 19 April 2022; Accepted: 20 April 2022;
Published: 04 May 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Favalli, Gobbini, Bombaci, Maioli, Biggioggero, Pesce, Favalli, Martinovic, Fabbris, Marchisio, Bandera, Gori, Abrignani, Grifantini and Caporali. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Ennio Giulio Favalli, enniofavalli@me.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.